Enter your email address in the box to the right of this page to receive email updates from the Life Sciences Hub when new content is published.
For those with an interest in life sciences, the rise to prominence of CRISPR, a transformational development in the field of molecular biology and genetics, has been impossible to ignore.
Welcome to our blog dedicated to Life Sciences. We report on EU and national regulatory, compliance, intellectual property and transactional developments in the sector. We focus on (bio)pharmaceuticals and medical technologies, and also cover food and beverages, cosmetics and other healthcare products.
11 July 2019 - Posted by: Eveline Van Keymeulen
Today is a big day for legal cannabis in France. Earlier this morning, the French National Agency for Medicines and Health Products Safety (ANSM) endorsed the medical cannabis pilot programme per the recommendations of the French specialised committee on cannabis (CSST) which were published on 28 June (see our earlier blog post: “French cannabis committee › Read More
02 July 2019 - Posted by: Tine Carmeliet
In Belgium, two recent events have drawn attention to the (online) pharmacy market. First, on 28 May 2019, the Competition Court of the Belgian Competition Authority (BCA) imposed a fine of EUR 1 million on the Belgian Order of Pharmacists for the use of anti-competitive practices aimed at excluding the MediCare-Market group, an association of (para)-pharmacies › Read More
01 July 2019 - Posted by: Laurie-Anne Ancenys
On 29 May 2019, the French National Ethical Consultative Committee for Life Sciences and Health (CCNE) delivered its Opinion (n°130) on ethical issues in connection with big data in the health sector (the Opinion). The Opinion aims at identifying the ethical challenges raised by the exploitation of large set of data in healthcare and provide › Read More
28 June 2019 - Posted by: Megan McMellon
On 18 June, Google and Sanofi announced a new collaboration aimed at accelerating healthcare innovation. The collaboration has three key objectives: to better understand patients and diseases; to increase Sanofi’s operational efficiency; and to improve the experience of Sanofi’s patients and customers. Google and Sanofi will develop an Innovation Lab to test and explore both › Read More
27 June 2019 - Posted by: Eveline Van Keymeulen
Yesterday, the French specialised committee on cannabis (CSST), which was established in mid-2018, held its last meeting and presented its final recommendations for the implementation of a medical cannabis pilot programme to the French National Agency for Medicines and Health Products Safety (ANSM). Last week, on 19 June 2019, the CSST had already published the › Read More